Nutex Health, Inc.NUTXNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
287.09%
↑ 149% above average
Average (39q)
-582.25%
Historical baseline
Range
High:10184.06%
Low:-30998.14%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 287.09% |
| Q2 2025 | -53.36% |
| Q1 2025 | -36.77% |
| Q4 2024 | 1081.96% |
| Q3 2024 | 82.35% |
| Q2 2024 | 265.55% |
| Q1 2024 | 105.54% |
| Q4 2023 | -3083.64% |
| Q3 2023 | -126.52% |
| Q2 2023 | 91.84% |
| Q1 2023 | -197.64% |
| Q4 2022 | 101.06% |
| Q3 2022 | -30998.14% |
| Q2 2022 | -104.71% |
| Q1 2022 | 88.19% |
| Q4 2021 | -79.13% |
| Q3 2021 | 169.75% |
| Q2 2021 | 765.18% |
| Q1 2021 | -106.55% |
| Q4 2020 | 10184.06% |
| Q3 2020 | 62.67% |
| Q2 2020 | -79.02% |
| Q1 2020 | 83.77% |
| Q4 2019 | -1492.36% |
| Q3 2019 | 2.92% |
| Q2 2019 | -2.07% |
| Q1 2019 | 34.74% |
| Q4 2018 | -53.28% |
| Q3 2018 | 24.95% |
| Q2 2018 | -18.70% |
| Q1 2018 | 88.21% |
| Q4 2017 | -390.64% |
| Q3 2017 | 42.98% |
| Q2 2017 | 0.00% |
| Q4 2011 | -0.13% |
| Q3 2011 | -22.87% |
| Q2 2011 | -14.11% |
| Q1 2011 | 61.78% |
| Q4 2010 | -44.05% |
| Q3 2010 | -11.02% |